The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

London open The FTSE 100 is expected to open 69 points lower on Friday, having closed up 0.28% on Thursday at 8,756.21.

Almost half of councils in England risk falling into bankruptcy without action to address a £4.6bn deficit amassed under a ...

Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...

GSK boss Walmsley (left) received £10.6m in salary and bonuses in 2024 while Blanc (right), head of insurance group Aviva, ...

One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare ...

GSK plc (LON:GSK – Get Free Report) insider Emma Walmsley sold 38,459 shares of the stock in a transaction dated Monday, February 17th. The stock was sold at an average price of GBX 1,418 ($17.92), ...